U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07625202) titled 'Creatine Supplementation During GLP-1a Therapy' on May 25.
Brief Summary: GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.
Study Start Date: May 25
Study Type: INTERVENTIONAL
Condition:
Sarcopenia
Intervention:
DIETARY_SUPPLEMENT: Dietary supplementation during a 12 week resistance-training program (creatine)
creatine supplementation
DIETARY_SUPPLEMENT: Dietary supplementation during a 12 week resistance-training program (placebo)
Place...